Strategic Patent Drafting for Biosimilars in India: Overcoming Key Sectional Barriers

Biosimilars are highly similar versions of already approved biologic medications. They are not identical to the reference product but are designed to have no clinically meaningful differences in terms of safety...

Read More

Empowering Green Innovation through IP: Exploring WIPO GREEN & IPC Green Inventory

In the previous post, we explored Green Technologies and their role in building a sustainable future. But how do these innovations reach the right hands and make a real impact? That’s where intellectual prop...

Read More